Caris Life Sciences, Inc.
Ticker: 2019410
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|
| INCOME | |||||
| Revenue | 263.71+22.0% | 216.17-0.3% | 216.83+19.5% | 181.40+50.0% | 120.92 |
| Total Income | 263.71+22.0% | 216.17-0.3% | 216.83+19.5% | 181.40+50.0% | 120.92 |
| EXPENSES | |||||
| Expenditure | 236.79+12.3% | 210.89+14.5% | 184.19-7.6% | 199.39+11.5% | 178.87 |
| Tax | 0.02+115.4% | -0.13 | 0.00 | 0.00 | 0.00 |
| PROFIT | |||||
| PBT | -0.61+4.7% | -0.64-102.6% | 24.33+133.9% | -71.79+30.0% | -102.58 |
| Net Profit | -0.64-25.5% | -0.51-102.1% | 24.33+133.9% | -71.79+30.0% | -102.58 |
| KEY METRICS | |||||
| OPM % | 10.21%+7.77pp | 2.44%-12.61pp | 15.05%+24.97pp | -9.92%+38.01pp | -47.93% |
| NPM % | -0.24%-0.01pp | -0.24%-11.45pp | 11.22%+50.79pp | -39.58%+45.26pp | -84.84% |
| EPS | 0.00 | 0.00-100.0% | 0.09+101.1% | -7.97-123.2% | -3.57 |
Corporate Events
Board MeetingCAI
20264Jun
Board Meeting
Shareholders voted on the election of ten director nominees …
SEC Filing ↗